Reading PG? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track PG free→Reading PG? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track PG free→NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but earnings quality is fragile, reported profits aren't backed by cash. Management's recent track record has been fairly steady, and risk is low, though the sector backdrop is a headwind. Peer multiples imply a price about 23% below where it trades (it looks expensive on this basis); the read is fair, but weakening, as it is priced roughly in line with peers, but recent financials or earnings quality are weakening. Key factors to watch include guidance changes and sector trends, as both could significantly impact performance. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 8 valuation methods, at three horizons. Current price $149.61. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $150 PG trades at 22× p/e, in line with its 18× p/e peer median. Our $122 fair value reflects that, medium confidence. Analysts: $142–$177. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 22% near-term growth, ahead of our forecast of about 8%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated strong grew net income 66% of the time over the next year (vs 53% for the rest of the cohort, n=1144).
Over the trailing year it converted 1.17x of net income into operating cash flow. Historically, Consumer Staples names rated fragile grew net income 51% of the time over the next year (vs 57% for the rest of the cohort, n=1037).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
4 material management or governance events in the past 24 months, led by executive changes. Historically, Consumer Staples names rated neutral grew net income 50% of the time over the next year (vs 48% for the rest of the cohort, n=491).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.42 → $1.42 (-0.2% / 30d). 0 raised, 15 cut, 18 covering analysts.
0 upgrades, 0 downgrades / 30d. 58% of analysts rate Buy.
1 PT revisions / 30d. Avg target 5.2% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$97.
How much price usually moves either way.
On a bad day, this stock has moved -$188.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,615.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Organic sales growth is key to P&G's growth strategy. A drop signals trouble.
Confirms:Q3 organic sales growth reported below 3% year over year.
Disproves:Q3 organic sales growth reported above 3% year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for PG yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 24, 2026 , The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended March 31, 2026. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$142.00 – $177.00 (median $163.00) · 9 analysts · as of 2026-06-11
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
A side-by-side read on sector standing, valuation, and risk versus Consumer Staples (broad).
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
PG Procter & Gamble | Typical Show detailsSector percentile: 67 of 100 | full | low |
WMT Walmart | Below typical Show detailsSector percentile: 30 of 100 | expensive | low |
COST Costco | Typical Show detailsSector percentile: 50 of 100 | expensive | low |
KO Coca-Cola Company (The) | Typical Show detailsSector percentile: 59 of 100 | expensive | low |
PM Philip Morris International | Typical Show detailsSector percentile: 41 of 100 | full | moderate |
Not investment advice. As of 2026-06-12.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
P&G aims to sustain its guidance for fiscal 2026 all-in sales growth between one to five percent.
P&G aims to maintain its fiscal 2026 EPS growth between one to six percent.
P&G aims for adjusted free cash flow productivity of 85% to 90% for fiscal 2026.
Why it matters: An update on EPS growth outlook shows how well the company manages costs and sales.
Confirms:Management raises EPS growth outlook for the next quarter above 5%.
Disproves:Management lowers EPS growth outlook below 3% for the next quarter.
Why it matters: Confirming sales growth guidance shows the company can grow despite challenges. It signals strength.
Confirms:Management confirms sales growth guidance of at least 5% for the upcoming quarter.
Disproves:Management expects sales growth to be less than 5% for the next quarter.
Why it matters: High free cash flow productivity shows the company is managing its cash well for growth.
Confirms:Free cash flow productivity exceeds 90% in the next quarter.
Disproves:Free cash flow productivity falls below 70% in the next quarter.
Why it matters: If sector revenue growth improves, it may help P&G's sales outlook. It shows market strength.
Confirms one read:Sector revenue growth picks up to above 6% year over year.
Confirms the other:Sector revenue growth declines below 4% year over year.
Why it matters: Higher commodity costs can hurt margins and profits. This is a key risk.
Confirms:Commodity costs rise a lot past the $150 million estimate.
Disproves:Commodity costs stay stable or go down.
Why it matters: Free cash flow productivity is vital for dividends and growth. A drop is concerning.
Confirms:Adjusted free cash flow is less than 85%.
Disproves:Adjusted free cash flow productivity is at or above 85%.
Why it matters: EPS growth guidance reflects profitability. A cut signals deeper issues.
Confirms:Guidance for EPS growth falls below 1% for fiscal 2026.
Disproves:EPS growth guidance remains at or above 1% for fiscal 2026.
REGULATION FD DISCLOSURE On April 14, 2026, The Procter & Gamble Company (the "Company") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0885 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2026, to Common Stock shareholders of record at the close of business on April 24, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock…
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 22, 2026 , The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended December 31, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."
REGULATION FD DISCLOSURE On January 13, 2026, The Procter & Gamble Company (the "Company") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2026, to Common Stock shareholders of record at the close of business on January 23, 2026, and to Series A and Series B ESOP Convertible Class A Prefer…
Chief Executive Officer - Health Care — Jennifer Davis: Jennifer Davis intends to retire after more than 33 years of service.